- Exosomes for delivery of nucleic acid-based agents - including mRNA, siRNA, antisense oligonucleotides, and CRISPR technologies.
- Exosomes for delivery of protein therapeutics - including antibodies, receptors and enzyme replacement therapies.
- Tailored targeting technology - directing exosomes to tissues and organs of interest.
- Proprietary exosome manufacturing and purification methods – cellular engineering technology, upstream optimization and downstream processing.
In addition to actively pursuing and protecting our ground-breaking exosome therapeutics we are always looking for opportunities to complement our growing IP estate. Please get in touch: firstname.lastname@example.org.